Peter Hokland - Concepedia

Author

Peter Hokland

Also Known As

Hokland, P., Hokland, P.; id_orcid 0000-0002-1177-9756, Hokland, Peter; id_orcid 0000-0002-1177-9756, Maria Hansen, P Hokland, P. HOKLAND, P. Hokland, PETER HOKLAND, Peter Hokland

406

Publications

9.4K

Citations

H-Index

125

Concepts

All Affiliations

Aarhus University Hospital Aarhus University Danish Cancer Society Rigshospitalet Karolinska Institutet

About

Peter Hokland is an author at Aarhus University Hospital specializing in medicine, hematology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	57	4.2K
2	Health Sciences	12	15	1.1K
3	Engineering	2	2	159
4	Natural Sciences	2	2	72
5	Public Health	1	1	22

Peter Hokland

141

Publications

8.6K

Citations

H-Index

Page 1

	Year	Citations
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program Emmanuel Beillard, Niels Pallisgaard, Vincent H. J. van der Velden, Leukemia Hematological MalignancyPolymerase Chain ReactionPrognostic BiomarkersMolecular Diagnostic TechniquesResidual Disease Detection	2003	879
Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery Lone Susanne Jensen, A J Andersen, P. Christiansen, British journal of surgery	1992	562
miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts Anna M. Eiring, Jason G. Harb, Paolo Neviani, Cell GeneticsMrna TranslationMir-328 FunctionsRna DecoyMicrorna Detection	2010	561
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia Anders Castor, Lars Nilsson, Ingbritt Åstrand‐Grundström, Nature Medicine Hematological MalignancyDistinct PatternsMedicineStem Cell MobilizationMixed-phenotype Acute Leukemia	2005	328
Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo Petter Woll, Una Kjällquist, Onima Chowdhury, Cancer Cell Hematological MalignancyBone Marrow FailureMyelodysplastic SyndromesMedicineMyeloid Neoplasia	2014	318
Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite of extensive proliferation Basem M. Abdallah, Mandana Haack‐Sørensen, Jorge S. Burns, Biochemical and Biophysical Research Communications Regenerative MedicineDevelopmental BiologyMedicineAdult Stem CellDifferentiation Potential	2004	263
Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Screening of 29 Translocations and Chromosomal Aberrations in Acute Leukemia Niels Pallisgaard, Peter Hokland, Dorthe C. Riishøj, Blood	1998	258
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells Paolo Neviani, Jason G. Harb, Joshua J. Oaks, Journal of Clinical Investigation	2013	215
<i>WT1</i> gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients – results from a single‐centre study Mette Østergaard, Lene Olesen, Henrik Hasle, British Journal of Haematology	2004	195
Promoter hypermethylation of <i>p15</i><sup><i>INK</i>4<i>B</i></sup>, <i>HIC1</i>, <i>CDH1</i>, and <i>ER</i> is frequent in myelodysplastic syndrome and predicts poor prognosis in early‐stage patients Anni Aggerholm, Mette Skov Holm, Per Guldberg, European Journal Of Haematology	2005	176

Page 1